OncoGxOne Plus

Physician Test
Please contact us via this form

A comprehensive Next Generation Sequencing (NGS) based test that detects cancer driving mutations for targeted selection and provides tools for immunotherapy recommendation.

  • 364 genes in total, 38 sequenced from DNA & RNA
  • Somatic Mutation Detection: SNV, indel, CNV and FUSION
  • Immuno-oncology solutions for anti-PD1 Therapy recommendations: Microsatellite Instability (MSI), Tumor Mutation Burden (TMB) , HLA-typing
  • Average depth of coverage exceeds 250x resulting in mutation detection with high specificity and sensitivity
Sample Type:Tissue
Suitable For:Individuals diagnosed with cancer
Lab Certification:CAP / CLIA
TAT:14 – 21 working days upon receipt of sample at Laboratory